nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis
|
Arslan, Doruk |
|
|
43 |
C |
p. |
artikel |
2 |
A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesion
|
Ataka, Takuya |
|
|
43 |
C |
p. |
artikel |
3 |
Adherence and drop-out in randomized controlled trials of exercise interventions in people with multiple sclerosis: A systematic review and meta-analyses
|
Dennett, Rachel |
|
|
43 |
C |
p. |
artikel |
4 |
A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.
|
Paz-Zulueta, Maria |
|
|
43 |
C |
p. |
artikel |
5 |
Altered resting-state functional connectivity density in patients with neuromyelitis optica-spectrum disorders
|
Wang, Yu |
|
|
43 |
C |
p. |
artikel |
6 |
A new look at an old test: Normative data of the symbol digit modalities test –Oral version
|
Strober, L.B. |
|
|
43 |
C |
p. |
artikel |
7 |
A new mouse model for human immune system-related translational studies
|
Zoledziewska, Magdalena |
|
|
43 |
C |
p. |
artikel |
8 |
AQP4-IgG-positive neuromyelitis optica spectrum disorder with late onset in Mexico.
|
Delgado-García, Guillermo |
|
|
43 |
C |
p. |
artikel |
9 |
Aquatic exercising may improve sexual function in females with multiple sclerosis – an exploratory study
|
Sadeghi Bahmani, Dena |
|
|
43 |
C |
p. |
artikel |
10 |
ATP1A3: an unusual antigen to consider in patients with subacute ataxia and vertical gaze palsy
|
Garcez, Daniela |
|
|
43 |
C |
p. |
artikel |
11 |
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
|
Safavi, Farinaz |
|
|
43 |
C |
p. |
artikel |
12 |
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab
|
Signoriello, E. |
|
|
43 |
C |
p. |
artikel |
13 |
Brain MRI features of Chinese Han patients with MOG-antibody disease
|
Li, Haiqing |
|
|
43 |
C |
p. |
artikel |
14 |
Clinical and MRI correlates of autonomic dysfunction in neuromyelitis optica spectrum disorder
|
Kwon, Soonwook |
|
|
43 |
C |
p. |
artikel |
15 |
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina
|
Liguori, Nora Fernández |
|
|
43 |
C |
p. |
artikel |
16 |
Corrigendum to: A new look at an old test: Normative data of the symbol digit modalities test–Oral version [Multiple Sclerosis and Related Disorders 43 (2020) 102154]
|
Strober, L.B. |
|
|
43 |
C |
p. |
artikel |
17 |
Dare we mention the C-word?
|
Giovannoni, Gavin |
|
|
43 |
C |
p. |
artikel |
18 |
DCLK-1 LEVEL IN MULTIPLE SCLEROSIS PATIENTS AND ITS CORRELATION WITH CLINIC
|
ŞİMŞEK, Fatma |
|
|
43 |
C |
p. |
artikel |
19 |
Development and validation of the communication and language assessment questionnaire for persons with multiple sclerosis (CLAMS)
|
El-Wahsh, S. |
|
|
43 |
C |
p. |
artikel |
20 |
Dorsal midbrain involvement in MRI as a core clinical manifestation for NMOSD diagnosis
|
Etemadifar, Masoud |
|
|
43 |
C |
p. |
artikel |
21 |
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis
|
Moraes, Andréa Gomes |
|
|
43 |
C |
p. |
artikel |
22 |
Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials
|
Xue, Tao |
|
|
43 |
C |
p. |
artikel |
23 |
Efficacy and safety of rituximab in multiple sclerosis: Experience from a developing country
|
Mathew, Thomas |
|
|
43 |
C |
p. |
artikel |
24 |
Engagement of people with multiple sclerosis to enhance research into the physiological effect of hyperbaric oxygen therapy
|
Moore, Lucy |
|
|
43 |
C |
p. |
artikel |
25 |
Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999–2018
|
Salehi, Zahra |
|
|
43 |
C |
p. |
artikel |
26 |
Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical – Paraclinical follow up study of a case
|
Afshar, Hale |
|
|
43 |
C |
p. |
artikel |
27 |
Exercise improves neurotrophins in multiple sclerosis independent of disability status
|
Banitalebi, Ebrahim |
|
|
43 |
C |
p. |
artikel |
28 |
Explanatory factors of balance confidence in persons with multiple sclerosis: Beyond the physical functions
|
Abasıyanık, Zuhal |
|
|
43 |
C |
p. |
artikel |
29 |
Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods Analysis
|
Penner, Iris-Katharina |
|
|
43 |
C |
p. |
artikel |
30 |
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
|
Ghajarzadeh, Mahsa |
|
|
43 |
C |
p. |
artikel |
31 |
Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation
|
Balashov, Konstantin |
|
|
43 |
C |
p. |
artikel |
32 |
Functional representation of the symbol digit modalities test in relapsing remitting multiple sclerosis
|
Grothe, Matthias |
|
|
43 |
C |
p. |
artikel |
33 |
Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics
|
Levine, Jesse M. |
|
|
43 |
C |
p. |
artikel |
34 |
Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody - positive cerebral cortical encephalitis not requiring anti - inflammatory therapy following the decrease in cytokine/chemokine levels
|
Takamatsu, Tomoko |
|
|
43 |
C |
p. |
artikel |
35 |
Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab
|
Auer, Michael |
|
|
43 |
C |
p. |
artikel |
36 |
Lower cortical gamma-aminobutyric acid level contributes to increased connectivity in sensory-motor regions in progressive MS
|
Droby, Amgad |
|
|
43 |
C |
p. |
artikel |
37 |
MOG-associated optic neuritis masquerading as NAION in an elderly woman: a case report
|
Schroeder, Anna |
|
|
43 |
C |
p. |
artikel |
38 |
Multiple sclerosis 2017 McDonald criteria are also relevant for Tunisians
|
Souissi, A. |
|
|
43 |
C |
p. |
artikel |
39 |
Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.
|
Calabrò, Rocco Salvatore |
|
|
43 |
C |
p. |
artikel |
40 |
Neuromyelitis optica in patients with myasthenia gravis: Two case-reports
|
Castro-Suarez, Sheila |
|
|
43 |
C |
p. |
artikel |
41 |
Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: Rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data
|
Gromisch, Elizabeth S. |
|
|
43 |
C |
p. |
artikel |
42 |
NMOSD or GFAP astrocytopathy? A case report
|
Zhang, Yue |
|
|
43 |
C |
p. |
artikel |
43 |
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules
|
Trewin, Benjamin P. |
|
|
43 |
C |
p. |
artikel |
44 |
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years
|
Oh, Jiwon |
|
|
43 |
C |
p. |
artikel |
45 |
Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study
|
Taylor, Thomas RP |
|
|
43 |
C |
p. |
artikel |
46 |
Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis
|
Maniscalco, Giorgia T. |
|
|
43 |
C |
p. |
artikel |
47 |
Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis
|
Cederberg, Katie L.J. |
|
|
43 |
C |
p. |
artikel |
48 |
Serum albumin level is associated with the severity of neurological dysfunction of NMOSD patients
|
Yao, Xiao-Ying |
|
|
43 |
C |
p. |
artikel |
49 |
Severe skin reactions associated with cladribine in people with multiple sclerosis
|
Mateo-Casas, M |
|
|
43 |
C |
p. |
artikel |
50 |
Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis
|
Lin, Boren |
|
|
43 |
C |
p. |
artikel |
51 |
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS
|
Vermersch, Patrick |
|
|
43 |
C |
p. |
artikel |
52 |
The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis
|
Talebi, Mahnaz |
|
|
43 |
C |
p. |
artikel |
53 |
The Effectiveness of New Adiposity Indices on Plasma Lipid Profile in Patients with Multiple Sclerosis: A Cross-Sectional Study with A Body Shape Index, Body Roundness Index, and Visceral Adiposity Index
|
Uzdil, Zeynep |
|
|
43 |
C |
p. |
artikel |
54 |
The effect of fampridine on the risk of seizure in patients with multiple sclerosis
|
Etemadifar, Masoud |
|
|
43 |
C |
p. |
artikel |
55 |
The 2015 IPND Criteria Increases the Yield in Diagnosis of Neuromyelitis Optica Spectrum Disorder in Thai Patients Compared to the 2006 Diagnostic Criteria
|
Rattanathamsakul, Natthapon |
|
|
43 |
C |
p. |
artikel |
56 |
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis
|
Yam, Charmaine |
|
|
43 |
C |
p. |
artikel |
57 |
The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder
|
Wu, Yifan |
|
|
43 |
C |
p. |
artikel |
58 |
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
|
Baker, David |
|
|
43 |
C |
p. |
artikel |
59 |
Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations
|
Guevara, Carlos |
|
|
43 |
C |
p. |
artikel |
60 |
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis
|
Carotenuto, Antonio |
|
|
43 |
C |
p. |
artikel |
61 |
Validity of the McDonald criteria in predicting second events in multiple sclerosis
|
Zhang, Kejia |
|
|
43 |
C |
p. |
artikel |
62 |
Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis
|
Muehler, Andreas |
|
|
43 |
C |
p. |
artikel |